Medfield Diagnostics AB (publ)

NGM:MEDF Stock Report

Market Cap: kr23.6m

Medfield Diagnostics Past Earnings Performance

Past criteria checks 0/6

Medfield Diagnostics's earnings have been declining at an average annual rate of -7.6%, while the Medical Equipment industry saw earnings growing at 5.8% annually. Revenues have been growing at an average rate of 17.9% per year.

Key information

-7.6%

Earnings growth rate

11.9%

EPS growth rate

Medical Equipment Industry Growth6.2%
Revenue growth rate17.9%
Return on equity-20.4%
Net Margin-208.9%
Last Earnings Update31 Dec 2023

Recent past performance updates

Recent updates

Is Medfield Diagnostics (NGM:MEDF) In A Good Position To Deliver On Growth Plans?

May 12
Is Medfield Diagnostics (NGM:MEDF) In A Good Position To Deliver On Growth Plans?

Is Medfield Diagnostics (NGM:MEDF) In A Good Position To Invest In Growth?

Dec 29
Is Medfield Diagnostics (NGM:MEDF) In A Good Position To Invest In Growth?

Companies Like Medfield Diagnostics (NGM:MEDF) Are In A Position To Invest In Growth

Sep 07
Companies Like Medfield Diagnostics (NGM:MEDF) Are In A Position To Invest In Growth

Revenue & Expenses Breakdown
Beta

How Medfield Diagnostics makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

NGM:MEDF Revenue, expenses and earnings (SEK Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 237-15180
30 Sep 239-12200
30 Jun 2310-10190
31 Mar 2310-9180
31 Dec 229-8170
30 Sep 228-7160
30 Jun 228-7160
31 Mar 228-7150
31 Dec 218-7150
30 Sep 218-7140
30 Jun 217-8140
31 Mar 217-7130
31 Dec 208-7130
30 Sep 207-9140
30 Jun 206-8140
31 Mar 204-8120
31 Dec 194-8120
30 Sep 194-9130
30 Jun 194-8120
31 Mar 194-8120
31 Dec 183-7110
30 Sep 183-5100
30 Jun 185-4110
31 Mar 184-5120
31 Dec 176-4120
30 Sep 176-3110
30 Jun 175-4110
31 Mar 175-3100
31 Dec 163-4100
30 Sep 166-3100
30 Jun 167-3100
31 Mar 166-3110
31 Dec 156-4110
30 Sep 152-8110
30 Jun 151-8100
31 Mar 151-880
31 Dec 141-660
30 Sep 141-550
30 Jun 141-440
31 Mar 141-440
31 Dec 131-440
30 Sep 131-330
30 Jun 131-340

Quality Earnings: MEDF is currently unprofitable.

Growing Profit Margin: MEDF is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: MEDF is unprofitable, and losses have increased over the past 5 years at a rate of 7.6% per year.

Accelerating Growth: Unable to compare MEDF's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: MEDF is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (30.1%).


Return on Equity

High ROE: MEDF has a negative Return on Equity (-20.36%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.